DK260976A - Fremgangsmade til fremstilling af delta9(11)-5alfa-20-ketosteroider - Google Patents
Fremgangsmade til fremstilling af delta9(11)-5alfa-20-ketosteroiderInfo
- Publication number
- DK260976A DK260976A DK260976A DK260976A DK260976A DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A DK 260976 A DK260976 A DK 260976A
- Authority
- DK
- Denmark
- Prior art keywords
- 5alfa
- delta9
- ketosteroids
- preparing
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2526373A DE2526373C2 (de) | 1975-06-11 | 1975-06-11 | Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden |
Publications (3)
Publication Number | Publication Date |
---|---|
DK260976A true DK260976A (da) | 1976-12-12 |
DK137837B DK137837B (da) | 1978-05-16 |
DK137837C DK137837C (da) | 1978-10-23 |
Family
ID=5948981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK260976A DK137837C (da) | 1975-06-11 | 1976-06-11 | Fremgangsmaade til fremstilling af delta9(11)-5alfa-20-ketopregnener |
Country Status (10)
Country | Link |
---|---|
US (1) | US4061661A (da) |
JP (1) | JPS51149260A (da) |
CH (1) | CH620452A5 (da) |
DD (1) | DD125699A5 (da) |
DE (1) | DE2526373C2 (da) |
DK (1) | DK137837C (da) |
FR (1) | FR2314197A1 (da) |
GB (1) | GB1554901A (da) |
HU (1) | HU174227B (da) |
NL (1) | NL7606137A (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2748442C3 (de) * | 1977-10-26 | 1981-08-27 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel |
US4252729A (en) * | 1978-05-12 | 1981-02-24 | Hoffmann-La Roche Inc. | Steroids and process for their manufacture |
US4252719A (en) * | 1978-08-17 | 1981-02-24 | Research Corporation | Steroid conversion method and products produced thereby |
DE2929558C2 (de) * | 1979-07-18 | 1982-03-11 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑ und/oder Δ↑1↑↑6↑ ungesättigten Steroiden |
US4328162A (en) * | 1980-09-05 | 1982-05-04 | Eastman Kodak Company | Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound |
US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
EP2766380B1 (en) | 2011-10-14 | 2019-04-24 | Sage Therapeutics, Inc. | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
US9512165B2 (en) | 2013-04-17 | 2016-12-06 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof |
WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
PL2986624T3 (pl) | 2013-04-17 | 2020-11-16 | Sage Therapeutics, Inc. | Neuroaktywne steroidy 19-NOR do stosowania w sposobach leczenia |
DK3021852T3 (da) | 2013-07-19 | 2021-03-15 | Sage Therapeutics Inc | Neuroaktive steroider, sammensætninger og anvendelser deraf |
CA3235088A1 (en) | 2013-08-23 | 2015-02-26 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
EP3206493B1 (en) | 2014-10-16 | 2020-05-06 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
SG10202009859YA (en) | 2014-10-16 | 2020-11-27 | Sage Therapeutics Inc | Compositions and methods for treating cns disorders |
US10774108B2 (en) | 2014-11-27 | 2020-09-15 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
EP3250210B1 (en) | 2015-01-26 | 2020-12-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
ES2935476T3 (es) | 2015-02-20 | 2023-03-07 | Sage Therapeutics Inc | Esteroides neuroactivos, composiciones y usos de los mismos |
US20180311258A1 (en) * | 2015-04-10 | 2018-11-01 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
JP7065825B2 (ja) | 2016-07-11 | 2022-05-12 | セージ セラピューティクス, インコーポレイテッド | C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法 |
DK3481845T3 (da) | 2016-07-11 | 2023-11-27 | Sage Therapeutics Inc | C17, c20 og c21 substituerede neuroaktive steroider og deres anvendelsesmetoder |
EP3712161A1 (en) * | 2019-03-19 | 2020-09-23 | Bionice, S.L.U. | Process for preparing high puritiy allopregnanolone and intermediates thereof |
US11643434B2 (en) | 2019-05-31 | 2023-05-09 | Sage Therapeutics, Inc. | Neuroactive steroids and compositions thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2681353A (en) * | 1952-03-11 | 1954-06-15 | Sterling Drug Inc | Chlorination of keto-steroids |
GB1380248A (en) * | 1970-12-17 | 1975-01-08 | Glaxo Lab Ltd | 3alpha-hydroxy steroids and esters thereof |
-
1975
- 1975-06-11 DE DE2526373A patent/DE2526373C2/de not_active Expired
-
1976
- 1976-06-08 US US05/693,848 patent/US4061661A/en not_active Expired - Lifetime
- 1976-06-08 NL NL7606137A patent/NL7606137A/xx not_active Application Discontinuation
- 1976-06-09 JP JP51067563A patent/JPS51149260A/ja active Granted
- 1976-06-09 DD DD193275A patent/DD125699A5/xx unknown
- 1976-06-09 GB GB23849/76A patent/GB1554901A/en not_active Expired
- 1976-06-09 CH CH726176A patent/CH620452A5/de not_active IP Right Cessation
- 1976-06-10 HU HU76SCHE569A patent/HU174227B/hu not_active IP Right Cessation
- 1976-06-11 DK DK260976A patent/DK137837C/da not_active IP Right Cessation
- 1976-06-11 FR FR7617698A patent/FR2314197A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2314197B1 (da) | 1981-03-20 |
CH620452A5 (da) | 1980-11-28 |
DE2526373A1 (de) | 1976-12-30 |
DK137837C (da) | 1978-10-23 |
FR2314197A1 (fr) | 1977-01-07 |
DD125699A5 (da) | 1977-05-11 |
DK137837B (da) | 1978-05-16 |
GB1554901A (en) | 1979-10-31 |
DE2526373C2 (de) | 1983-11-10 |
US4061661A (en) | 1977-12-06 |
HU174227B (hu) | 1979-11-28 |
NL7606137A (nl) | 1976-12-14 |
JPS51149260A (en) | 1976-12-22 |
JPS6146480B2 (da) | 1986-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK298176A (da) | Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater | |
DK260976A (da) | Fremgangsmade til fremstilling af delta9(11)-5alfa-20-ketosteroider | |
DK143706C (da) | Fremgangsmaade til fremstilling af svovlholdige organosiliciumforbindelser | |
DK484576A (da) | Fremgangsmade til fremstilling af 2-aroyl-3-phenyl-benzothiophenforbindelser | |
DK87876A (da) | Fremgangsmade til fremstilling af n-acyl-l-metionin | |
DK243176A (da) | Fremgangsmade til fremstilling af polycliske forbindelser | |
DK164476A (da) | Fremgangsmade til fremstilling af piperazinylpyrazinforbindelser | |
DK324776A (da) | Fremgangsmade til fremstilling af 3-cyanoimino-3-aminopropionitriler | |
DK164376A (da) | Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner | |
DK554076A (da) | Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ] | |
DK372576A (da) | Fremgangsmade til fremstilling af polyaminforbindelser | |
DK305876A (da) | Fremgangsmade til fremstilling af l-pyroglutamyl-l-prolinamid | |
DK362676A (da) | Fremgangsmade til fremstilling af 1,4-dihydropyridiner | |
DK155598C (da) | Fremgangsmaade til fremstilling af ethylchlorthioformiat | |
DK283476A (da) | Fremgangsmade til fremstilling af beta-acylpyrroler | |
DK143137C (da) | Fremgangsmaade til fremstilling af phosphitchlorider | |
DK143281C (da) | Fremgangsmaade til fremstilling af phosphitchlorider | |
DK219776A (da) | Fremgangsmade til fremstilling af 1,2-benzothiazin-oxadiazolforbindelse | |
DK280376A (da) | Fremgangsmade til fremstilling af 1-acyl-1,2,3,4-tetrahydro-6-quinoliner | |
DK260876A (da) | Fremgangsmade til fremstilling af delta9(11)-5alfa-d-homo-20-ketosteroider | |
DK140576A (da) | Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater | |
DK149803C (da) | Fremgangsmaade til fremstilling af 1,2-dichlorethan | |
DK544476A (da) | Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether | |
DK192576A (da) | Fremgangsmade til fremstilling af 7-methoxycephalosporin-derivater | |
DK49276A (da) | Fremgangsmade til fremstilling af biphenylylethere |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |